Evaluation of Rabies Virus Vectored Ebola Vaccine

907
Ebola
Evaluation of Rabies Virus Vectored Ebola Vaccine
Pennsylvania, USA
United States of America
To design and evaluate a thermostable Rabies Virus Vectored Ebola Vaccine. As Ebola exists in some of the poorest parts of the world where the climate is tropical, the development of a thermostable vaccine could be cost-effective, resulting in greater long-term vaccine stability in high ambient temperatures.
Thomas Jefferson University (National Institutes of Health)
CDC's National Center for Emerging and Zoonotic Infectious Diseases
Subscribe to Rabies